Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.

被引：0
|
作者：
Couvillon, Anna
Turkbey, Baris
Lindenberg, Maria Liza
Choyke, Peter L.
Martinez, Mirna
McKinney, Yolanda
Kaushal, Aradhana
Citrin, Deborah E.
Krauze, Andra
McNally, Deborah
Giordano, Luz
Chun, Guinevere
Royce, Cheryl
Han, Hui
Karzai, Fatima
Parnes, Howard L.
Pinto, Peter A.
Gulley, James L.
Dahut, William L.
Madan, Ravi Amrit
机构：
[1] NIH, Bethesda, MD 20892 USA
[2] NIH, Mol Imaging Program, NCI, Bethesda, MD 20892 USA
[3] NIH, Ctr Canc Res, NCI, Bethesda, MD 20892 USA
[4] NIH, NCI, Bethesda, MD 20892 USA
[5] Ctr Canc Res, Mol Imaging Program, Bethesda, MD USA
[6] NIH, Radiat Oncol Branch, NCI, Bethesda, MD 20892 USA
[7] NIH, Genitourinary Malignancies Branch, NCI, Bethesda, MD 20892 USA
[8] NIH, Urol Oncol Branch, NCI, Bethesda, MD 20892 USA
[9] NIH, Canc Prevent Div, NCI, Bethesda, MD 20892 USA
[10] NIH, Canc Prevent Div, NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
122
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.
    Couvillon, Anna
    Turkbey, Baris
    Lindenberg, Maria Liza
    Choyke, Peter L.
    Kaushal, Aradhana
    Citrin, Deborah E.
    Krauze, Andra V.
    McNally, Deborah
    McKinney, Yolanda
    Martinez, Mirna
    Han, Hui
    Karzai, Fatima
    Parnes, Howard L.
    Pinto, Peter A.
    Gulley, James L.
    Dahut, William L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] The Role of Fast and Deep PSA Response in Castration-sensitive Prostate Cancer
    Iacovelli, Roberto
    Ciccarese, Chiara
    Caffo, Orazio
    De Giorgi, Ugo
    Basso, Umberto
    Tucci, Marcello
    Mosillo, Claudia
    Maruzzo, Marco
    Maines, Francesca
    Casadei, Chiara
    Milella, Michele
    Tortora, Giampaolo
    ANTICANCER RESEARCH, 2022, 42 (01) : 165 - 172
  • [3] Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer.
    Chakraborty, Goutam
    Hirani, Rahim
    Nandakumar, Subhiksha
    Kalidindi, Teja Muralidhar
    Fidele, Deborah
    Rajanala, Sai Harisha
    Mazzu, Ying Zhang
    Yoshikawa, Yuki
    Jehane, Lina E.
    Lee, Gwo-Shu Mary
    de Stanchina, Elisa
    Sowalsky, Adam G.
    Morris, Michael J.
    Schoder, Heiko
    Pillarsetty, Naga Vara Kishore
    Mucci, Lorelei A.
    Danila, Daniel Costin
    Kantoff, Philip W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [4] PSMA PET findings in patients with undetectable PSA more than 3 years after docetaxel for metastatic castration-sensitive prostate cancer (mCSPC).
    Atiq, Mohammad O.
    Gandhy, Shruti U.
    Karzai, Fatima
    Al Harthy, Munjid
    Chen, Gang
    Bilusic, Marijo
    VanderWeele, David James
    Chandran, Elias Bin Aris
    Cordes, Lisa M.
    Owens, Helen
    Couvillon, Anna
    Hankin, Amy
    Williams, Monique
    Figg, William Douglas
    Choyke, Peter L.
    Lindenberg, Liza
    Mena, Esther
    Dahut, William L.
    Gulley, James L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17046 - E17046
  • [5] Effects of docetaxel on circulating immune cell subsets and association with outcomes in metastatic castration-sensitive prostate cancer.
    Chandran, Elias
    Goswami, Meghali
    Donahue, Renee Nicole
    Atiq, Mohammad O.
    Karzai, Fatima
    Bilusic, Marijo
    Marte, Jennifer L.
    Arlen, Philip M.
    Cordes, Lisa M.
    Owens, Helen
    Hausler, Megan
    Hankin, Amy
    Williams, Monique
    Dahut, William L.
    Figg, William Douglas
    Schlom, Jeffrey
    Gulley, James L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [6] Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
    Sutera, Philip
    Van der Eecken, Kim
    Shetty, Amol
    Song, Yang
    Hodges, Theresa
    Verbeke, Sofie
    Van Dorpe, Jo
    Fonteyne, Valerie
    De laere, Bram
    Mishra, Mark V.
    Rana, Zaker Hamid
    Molitoris, Jason K.
    Ferris, Matthew J.
    Roberts, Nicholas J.
    Song, Daniel Y.
    DeWeese, Theodore L.
    Pienta, Kenneth J.
    Deek, Matthew
    Ost, Piet
    Tran, Phuoc T.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Evaluating the optimal sequence of immunotherapy and docetaxel in men with metastatic castration-sensitive prostate cancer.
    Chandran, Elias Bin Aris
    Atiq, Mohammad O.
    Donahue, Renee Nicole
    Karzai, Fatima
    Bilusic, Marijo
    Marte, Jennifer L.
    Arlen, Philip M.
    Cordes, Lisa M.
    Owens, Helen
    Hankin, Amy
    Williams, Monique
    Figg, William Douglas
    Dahut, William L.
    Schlom, Jeffrey
    Gulley, James L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
    Gotto, Geoffrey T.
    Yip, Steven M.
    Shayegan, Bobby
    O'Sullivan, Dylan E.
    Wallis, Christopher J. D.
    Basappa, Naveen S.
    Cagiannos, Ilias
    Hamilton, Robert James
    Ferrario, Cristiano
    Fernandes, Ricardo
    Danielson, Brita
    Saad, Fred
    Hotte, Sebastien J.
    Brenner, Darren R.
    Cheung, Winson Y.
    Boyne, Devon J.
    Chan, Katherine
    Osborne, Brendan
    Zardan, Anousheh
    Malone, Shawn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [9] Association of very deep prostate-specific antigen (PSA) decline with longer radiologic-progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer.
    Kapar, Caner
    Tugcu, Volkan
    Sahin, Selcuk
    Guler, Haydar
    Kilickap, Saadettin
    Tural, Deniz
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.
    Appukkuttan, Sreevalsa
    Williams, Troy
    Jhaveri, Jay
    Campbell, David
    Kong, Sheldon
    Kalayeh, Bashir
    Ramsey, Scott David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 63 - 63
12345